Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity

Abstract

In recent times, laser treatment combined with intravitreal bevacizumab (Avastin) has been used rarely as early investigations to treat patients with aggressive posterior retinopathy of prematurity (ROP). We describe choroidal ruptures that were documented at 10 weeks after this combined treatment in a preterm infant born at 28 weeks gestation with a birth weight of 1190 g. Aggressive posterior ROP was diagnosed at the age of 6 weeks. Initial treatment included bilateral laser ablation, followed immediately by intravitreal bevacizumab (IVB, 0.75 mg) in the right eye. On day 5, a remarkable regression of plus sign and fibrovascular proliferation was noted only in the right eye. At this point, additional laser treatment combined with IVB was given in the left eye, which dramatically resolved plus disease and neovascularization. At 10 weeks after IVB in the left eye, two sites of choroidal ruptures were revealed along the posterior edges of laser scars. There was no evidence of choroidal neovascularization associated with the choroidal ruptures. Choroidal rupture may occur shortly after laser ablation plus IVB treatment for aggressive posterior ROP. This occurrence requires recognition to determine whether it is actually related to the treatment. Long-term follow-up is important for understanding the nature and progression of this potentially serious complication.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Chung EJ, Kim JH, Ahn HS, Koh HJ . Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1727–1730.

    Article  CAS  Google Scholar 

  2. Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008; 92: 1450–1455.

    Article  CAS  Google Scholar 

  3. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV . Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 2008; 28: S19–S25.

    Article  Google Scholar 

  4. Honda S, Hirabayashi H, Tsukahara Y, Negi A . Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1061–1063.

    Article  CAS  Google Scholar 

  5. Atmaca LS, Yilmaz M . Changes in the fundus caused by blunt ocular trauma. Ann Ophthalmol 1993; 25: 447–452.

    CAS  PubMed  Google Scholar 

  6. Estafanous MF, Seeley M, Traboulsi EI . Choroidal rupture associated with forceps delivery. Am J Ophthalmol 2000; 129: 819–820.

    Article  CAS  Google Scholar 

  7. Park P, Eagle Jr RC, Tasman WS . Diode laser photocoagulation for retinopathy of prematurity: a histopathologic study. Ophthalmic Surg Lasers 2001; 32: 63–66.

    CAS  PubMed  Google Scholar 

  8. Baba T, Grebe R, Hasegawa T, Bhutto I, Merges C, McLeod DS et al. Maturation of the fetal human choriocapillaris. Invest Ophthalmol Vis Sci 2009; 50: 3503–3511.

    Article  Google Scholar 

  9. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 2005; 167: 1451–1459.

    Article  CAS  Google Scholar 

  10. Yi X, Mai LC, Uyama M, Yew DT . Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats. Exp Brain Res 1998; 118: 155–160.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L-O Atchaneeyasakul.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atchaneeyasakul, LO., Trinavarat, A. Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. J Perinatol 30, 497–499 (2010). https://doi.org/10.1038/jp.2009.166

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2009.166

Keywords

This article is cited by

Search

Quick links